[go: up one dir, main page]

PL2268607T3 - Pochodne kwasu peptydonukleinowego o dobrej penetracji komórek i silnym powinowactwie do kwasu nukleinowego - Google Patents

Pochodne kwasu peptydonukleinowego o dobrej penetracji komórek i silnym powinowactwie do kwasu nukleinowego

Info

Publication number
PL2268607T3
PL2268607T3 PL09719041T PL09719041T PL2268607T3 PL 2268607 T3 PL2268607 T3 PL 2268607T3 PL 09719041 T PL09719041 T PL 09719041T PL 09719041 T PL09719041 T PL 09719041T PL 2268607 T3 PL2268607 T3 PL 2268607T3
Authority
PL
Poland
Prior art keywords
nucleic acid
strong affinity
cell penetration
good cell
acid derivatives
Prior art date
Application number
PL09719041T
Other languages
English (en)
Inventor
Shin Chung
Jong-Ook Lee
Heui-Yeon Kim
Hyun-Jin Park
Mi-Ran Kim
Original Assignee
Cti Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cti Bio filed Critical Cti Bio
Publication of PL2268607T3 publication Critical patent/PL2268607T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003Peptide-nucleic acids (PNAs)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL09719041T 2008-03-14 2009-03-13 Pochodne kwasu peptydonukleinowego o dobrej penetracji komórek i silnym powinowactwie do kwasu nukleinowego PL2268607T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20080023658 2008-03-14
KR20080111459 2008-11-11
PCT/KR2009/001256 WO2009113828A2 (en) 2008-03-14 2009-03-13 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
EP20090719041 EP2268607B9 (en) 2008-03-14 2009-03-13 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid

Publications (1)

Publication Number Publication Date
PL2268607T3 true PL2268607T3 (pl) 2015-09-30

Family

ID=41065678

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09719041T PL2268607T3 (pl) 2008-03-14 2009-03-13 Pochodne kwasu peptydonukleinowego o dobrej penetracji komórek i silnym powinowactwie do kwasu nukleinowego

Country Status (18)

Country Link
US (4) US8680253B2 (pl)
EP (1) EP2268607B9 (pl)
JP (1) JP5620282B2 (pl)
KR (2) KR20090098710A (pl)
CN (1) CN102015628B (pl)
AU (1) AU2009224149B2 (pl)
BR (1) BRPI0906104B8 (pl)
CA (1) CA2715844C (pl)
DK (1) DK2268607T5 (pl)
ES (1) ES2533769T3 (pl)
IL (4) IL207617A (pl)
MX (1) MX2010009687A (pl)
NZ (1) NZ587448A (pl)
PL (1) PL2268607T3 (pl)
PT (1) PT2268607E (pl)
RU (1) RU2564032C2 (pl)
WO (1) WO2009113828A2 (pl)
ZA (1) ZA201005960B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198825B (en) 1987-03-09 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Synergic fungicides
US9234059B2 (en) 2008-07-16 2016-01-12 Outlast Technologies, LLC Articles containing functional polymeric phase change materials and methods of manufacturing the same
US8221910B2 (en) 2008-07-16 2012-07-17 Outlast Technologies, LLC Thermal regulating building materials and other construction components containing polymeric phase change materials
AU2010306646B2 (en) * 2009-10-16 2016-09-01 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
PH12012500734A1 (en) 2009-10-16 2012-11-26 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
SG10201406634VA (en) * 2009-10-16 2014-11-27 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
US9216979B2 (en) 2009-10-16 2015-12-22 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
JP6317669B2 (ja) 2011-04-15 2018-04-25 メリンタ セラピューティクス インコーポレイテッド 抗菌化合物ならびにそれを作製および使用する方法
CN103031337A (zh) * 2012-09-28 2013-04-10 北京吉利奥生物科技发展有限公司 一种小核酸分子快递技术
AU2014315045A1 (en) 2013-09-09 2016-03-24 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
EP3039025A4 (en) 2013-09-09 2017-05-31 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
KR20180015114A (ko) 2015-03-11 2018-02-12 멜린타 테라퓨틱스, 인크. 항미생물 화합물 및 이의 제조 및 사용 방법
CN108473574A (zh) * 2015-10-20 2018-08-31 索伦托治疗有限公司 细胞内递送化合物
EP3452479A1 (en) 2016-05-06 2019-03-13 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same
EP3497114B1 (en) * 2016-08-08 2024-10-16 Olipass Corporation Androgen receptor antisense oligonucleotides
EP3512870B1 (en) * 2016-09-16 2022-08-03 Olipass Corporation Scn9a antisense oligonucleotides
CN110248956B (zh) * 2016-10-11 2023-02-21 奥利通公司 HIF-1α反义寡核苷酸
ES3038159T3 (en) 2016-11-16 2025-10-09 Academisch Ziekenhuis Leiden Substances for targeting various selected organs or tissues
BR112019011692A2 (pt) * 2016-12-30 2019-10-22 Olipass Corp salto de exon por derivados de ácido nucleico de peptídeo
KR102483119B1 (ko) * 2017-01-06 2023-01-02 올리패스 주식회사 Snap25 안티센스 올리고뉴클레오타이드
RU2762293C2 (ru) * 2017-01-24 2021-12-17 Олипасс Корпорейшн Антисмысловое для scn9a обезболивающее средство
KR102236495B1 (ko) * 2017-07-24 2021-04-06 올리패스 주식회사 티로시나아제 안티센스 올리고뉴클레오티드
KR20190011181A (ko) * 2017-07-24 2019-02-01 올리패스 주식회사 티로시나아제 안티센스 올리고뉴클레오티드
TWI832851B (zh) * 2018-05-18 2024-02-21 韓商奧利通公司 基質金屬蛋白酶-1之反義寡核苷酸
KR102304280B1 (ko) * 2018-08-14 2021-09-23 올리패스 주식회사 아세틸코에이카복실라제2 안티센스 올리고뉴클레오티드
KR20210010362A (ko) * 2019-07-18 2021-01-27 주식회사 올리패스코스메슈티컬즈 멜라노필린 안티센스 올리고뉴클레오티드
KR20210151593A (ko) 2020-06-05 2021-12-14 넥스올리고(주) 신규한 몰포리노 올리고뉴클레오티드 유도체
KR20240172540A (ko) * 2023-06-01 2024-12-10 주식회사 기프티드엠에스 세포 투과가 가능한 펩타이드-핵산 올리고머를 유효성분으로 포함하는 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물
KR102633299B1 (ko) 2023-09-08 2024-02-02 국방과학연구소 세포 투과가 가능한 펩타이드 핵산 올리고머를 유효성분으로 포함하는 한탄바이러스 감염 질환 치료용 약학적 조성물
WO2025219570A1 (en) 2024-04-17 2025-10-23 Johannes Kepler Universität Linz Composition for inhibiting protein translocation and methods using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US6133444A (en) 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
DE10019136A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
CN1814614A (zh) * 2005-02-06 2006-08-09 中国人民解放军军事医学科学院毒物药物研究所 核酸、肽核酸衍生物及它们的用途
US7960360B2 (en) 2006-11-13 2011-06-14 Jennifer Rubin Grandis Antisense guanidinium peptide nucleic acid (GPNA) oligonucleotides as antitumor agents

Also Published As

Publication number Publication date
DK2268607T5 (en) 2015-07-20
CN102015628A (zh) 2011-04-13
DK2268607T3 (en) 2015-03-23
HK1155717A1 (en) 2012-05-25
CA2715844A1 (en) 2009-09-17
WO2009113828A2 (en) 2009-09-17
US8895734B2 (en) 2014-11-25
RU2564032C2 (ru) 2015-09-27
JP5620282B2 (ja) 2014-11-05
ES2533769T3 (es) 2015-04-15
IL236514A0 (en) 2015-08-31
NZ587448A (en) 2012-03-30
RU2010135635A (ru) 2012-03-10
MX2010009687A (es) 2010-12-21
IL207617A (en) 2016-07-31
JP2011518770A (ja) 2011-06-30
US8884008B2 (en) 2014-11-11
US20120040918A9 (en) 2012-02-16
US20140155604A1 (en) 2014-06-05
WO2009113828A3 (en) 2009-12-23
IL236513A0 (en) 2015-08-31
KR20110010691A (ko) 2011-02-07
BRPI0906104B1 (pt) 2021-03-30
CA2715844C (en) 2015-11-24
EP2268607B9 (en) 2015-05-13
WO2009113828A9 (en) 2009-11-05
US20140323728A1 (en) 2014-10-30
IL207617A0 (en) 2010-12-30
US8680253B2 (en) 2014-03-25
EP2268607A2 (en) 2011-01-05
AU2009224149B2 (en) 2013-01-24
AU2009224149A1 (en) 2009-09-17
US20110178031A1 (en) 2011-07-21
PT2268607E (pt) 2015-04-07
BRPI0906104B8 (pt) 2021-05-25
EP2268607A4 (en) 2013-11-13
ZA201005960B (en) 2016-06-29
ES2533769T9 (es) 2016-05-13
BRPI0906104A2 (pt) 2015-06-30
EP2268607B1 (en) 2015-02-18
KR101598423B1 (ko) 2016-03-02
US8859766B2 (en) 2014-10-14
CN102015628B (zh) 2015-04-22
IL236515A0 (en) 2015-08-31
KR20090098710A (ko) 2009-09-17
US20140155605A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
IL236514A0 (en) History of peptide nucleic acids with good cell permeability and strong affinity for nucleic acid
IL267138A (en) Improved composition of cells and methods for its preparation
PL2334831T3 (pl) Sól anionu pentacyklicznego i jej zastosowanie jako elektrolit
EP2260528A4 (en) ELECTROCHEMICAL CELL AND THE SAME MEMBRANES
EP2376920A4 (en) METHOD FOR DETECTING CHANGES IN CELLS
PT2612926T (pt) Métodos para utilização de mirna para deteção de morte celular in vivo
EP2262038A4 (en) Cell selector and cell with it
EP2306567A4 (en) FUEL CELL
EP2245686A4 (en) COVERS FOR ELECTROCHEMICAL CELLS AND RELATED METHODS
EP2208795A4 (en) NUCLEIC ACID DETECTION METHOD AND NUCLEIC ACID DETERGENT KIT
EP2343759A4 (en) BATTERY COMPONENT AND BATTERY
ZA201100019B (en) Variant hhip1 protein and methods and uses thereof
EP2389307A4 (en) UNDER FRAMES WITH A GUIDE AND VEHICLE COMPRISING VEHICLE
TWI369495B (en) Cell detecting method
GB0812845D0 (en) Electrochemical assay
GB0609926D0 (en) Electrochemical cell
EP2405001A4 (en) NUCLEIC ACID COMPLEX AND NUCLEIC ACID DELIVERING COMPOSITION
EP2236011A4 (en) DEVICE AND METHOD FOR DETECTING AN ELECTROCHEMICAL COMPOSITION
GB2461390B (en) Composite electrochemical cell
PL386511A1 (pl) Ogniwo paliwowe
GB0819611D0 (en) Electrochemical cells and components thereof
GB0811949D0 (en) Cell sample enrichment
AU2008901448A0 (en) Improved Electrochemical Cell
IL207138A0 (en) Cell populations for polypeptide analysis and uses of same
IL244553A0 (en) Altered placental cells